UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) July 20, 2005
-------------
IMS HEALTH INCORPORATED
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
001-14049 06-1506026
--------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
1499 Post Road, Fairfield, Connecticut 06824
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(203) 319-4700
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
N/A
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|X| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|X| Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On July 20, 2005, IMS Health Incorporated issued a press release regarding
financial results for the second quarter ended June 30, 2005. A copy of this
press release is being furnished as Exhibit 99.1 to this Current Report on Form
8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in
this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liability of that section other than for purposes of
Rule 14a-12 of the Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 other
than for purposes of Rule 425 of the Securities Act of 1933.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements of Businesses Acquired.
None
(b) Pro Forma Financial Information.
None
(c) Exhibits.
The following exhibit is furnished as part of this report:
Exhibit Number Description
-------------- -----------
99.1 Press Release dated July 20, 2005
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IMS HEALTH INCORPORATED
By: /s/ Robert H. Steinfeld
---------------------------
Name: Robert H. Steinfeld
Title: Senior Vice President, General Counsel
and Corporate Secretary
Date: July 20, 2005
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------
99.1 Press Release dated July 20, 2005